Measuring concentration of serum syndecan-1 to assess vascular endothelial glycocalyx injury during hemodialysis
Not Applicable
- Conditions
- Chronic Renal Failure/hemodialysis
- Registration Number
- JPRN-UMIN000045020
- Lead Sponsor
- Gifu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 145
Inclusion Criteria
Not provided
Exclusion Criteria
Patients aged <20 years, died, underwent plasma apheresis, plasma exchange and double filtration plasma therapy, and who had not maintained the dry weight were excluded from the analysis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients' baseline characteristics are presented as median and interquartile range (IQR) for continuous variables, and frequency and proportion for categorical variables. For the primary analysis, a mixed effect model was used to assess the change in syndecan-1 levels with hemodialysis.
- Secondary Outcome Measures
Name Time Method